Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry

1. McMurray JJ, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004. 2. Perlman A, Hirsh Raccah B, Matok I, Muszkat M. Cognition and dementia related adverse effects with sacubitril-valsartan: analysis of the FDA Adverse Event Report System Database. 2018. J Card Fail. 2018;24:533–536. 3. Patel N, Gluck J. Is Entresto good for the brain? World J Cardiol. 2017;9:594. 4. Wooster J, Cook EA, Shipman D. Psychiatric manifestations with sacubitril/valsartan: a case report. J Pharm Pract. 2019. http://dx.doi.org/10.1177/0897190019842700. 5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5. ed. Arlington: American Psychiatric Association; 2013. p. 110-115. [(1032)TD.ENIM] https://doi.org/10.1016/j.rec.2020.05.033 1885-5857/